DXC Technology Company (DXC) Stock Price & How to Invest

DXC Technology was formed in 2017 from the merger of Computer Sciences Corporation (CSC) and the enterprise services arm of Hewlett Packard Enterprise. It manages and modernizes technology for large companies and governments in roughly 70 countries, through two main segments: Global Infrastructure Services (GIS), which runs data centers, cloud, workplace and security operations, and Consulting and Engineering Services (CES), which covers application development, analytics, engineering and industry software, plus a large insurance software and business process unit. Much of its work is long-term outsourcing contracts on mission-critical systems, which makes revenue sticky but also exposes it to steady erosion as clients renegotiate, insource or move work to cheaper rivals and hyperscale clouds. The scale is still large: DXC employs on the order of 120,000 people and counts many Fortune 500 banks, insurers, airlines, automakers and government agencies as clients, often for systems that cannot be switched off for even an hour.

The investment picture is a classic value-trap-or-turnaround debate. Revenue has fallen almost every year since the merger, to about $12.6 billion in fiscal 2026 (ended March 2026), and management guided fiscal 2027 to an organic decline of 3% to 5%. A miss on organic revenue in May 2026 sent the shares down about 21% in a day. Yet the company still produces roughly $700 million a year of free cash flow against a market value of only about $2.3 billion, buys back stock and pays down debt. CEO Raul Fernandez is repositioning DXC as an AI-led services firm, with offerings such as the OASIS orchestration platform, and the market is pricing in skepticism that this can offset the shrinking legacy base. Debt reduction is part of the same story, with net debt cut by roughly $270 million in the June 2026 quarter alone. For anyone looking at the shares, the debate is less about whether DXC is cheap, which it plainly is on current numbers, and more about how many years of shrinking revenue the current cash flow has to survive.

The core risk is that the revenue decline keeps compounding: organic revenue fell about 6.7% in the June 2026 quarter, worse than the full-year guidance midpoint, and a business that shrinks fast enough can see cash flow fall with it. Generative AI could deflate pricing across IT services, hitting the labor-based maintenance work that makes up much of DXC's base. The company has a history of guidance misses, leadership turnover and restructuring charges, and law firms announced investigations after the May 2026 miss, though no new class action had been reported as filed as of October 2026. DXC also carries several billion dollars of debt and lease obligations, so a deterioration in cash flow would narrow its room for buybacks. Currency is another swing factor, since a large share of revenue comes from Europe, Australia and other non-US markets, so a stronger dollar reduces reported results. Finally, outsourcing renewals tend to come in lumps, and a quarter with several large contracts up for renegotiation can show price cuts that persist for the life of the new deal.

7 analysts publish price targets on DXC, averaging $11.21 against a $13.62 price as of October 2026, or -17.7%. The published targets run from $9.00 to $14.00, a moderate spread, and the ratings split 0 buy, 7 hold, 1 sell. Over the last six months there has been 1 raise and 5 cuts among the published actions. A price target is what an analyst published on a date, not a prediction, and sell-side ratings skew positive across the whole market.

Read the full DXC forecast and price target for the target table, the recent rating actions by firm, and how the consensus has shifted.

We give no verdict on DXC Technology Company. Both cases are real, which is why the question is contested at all, so here is the strongest version of each.

The case for buying. Stabilizing bookings. The single most watched number at DXC is book-to-bill, the ratio of new contracts signed to revenue recognized. The most optimistic published target, $14.00, assumes this works close to its best case.

The case against. The core risk is that the revenue decline keeps compounding: organic revenue fell about 6.7% in the June 2026 quarter, worse than the full-year guidance midpoint, and a business that shrinks fast enough can see cash flow fall with it. The most pessimistic target, $9.00, is roughly what DXC is worth if this bites instead.

Read the full bull and bear case on DXC, including what would have to change to break either one. Walnut is not an investment adviser.

A simple financial snapshot. These are approximations and refresh quarterly; for current figures see DXC Technology Company's investor relations page or your broker.

• Revenue (TTM): ~$12.5 billion
• FY2027 revenue guidance: ~$12.1 to $12.35 billion (organic -3% to -5%)
• Non-GAAP EPS guidance (FY2027): ~$2.40 to $2.90
• Free cash flow (FY2026): ~$713 million
• Market cap: ~$2.3 billion (share price ~$13.79 at the October 15, 2026 close)
• Forward P/E (non-GAAP): ~4.8x to 5.7x

At about $13.79 a share (the October 15, 2026 close, within a 52-week range of roughly $7.90 to $15.68), DXC trades at about 4.8 to 5.7 times its guided non-GAAP earnings and a double-digit free cash flow yield, among the lowest multiples in large-cap IT services. That discount reflects years of shrinking revenue and repeated misses rather than an overlooked bargain by default, and analyst coverage in mid-2026 was uniformly at Hold with targets near $11. The next earnings report, for the September 2026 quarter, was expected around October 29, 2026, with options implying a move of roughly 15%. For comparison, larger rivals such as Accenture have historically traded at well over 20 times earnings, and even fellow turnaround Kyndryl has carried a materially higher multiple, which shows how much of DXC's discount is tied to its specific growth record rather than the sector as a whole.

Other names that sit close to DXC: same theme, named as a direct competitor, or held beside it in the same funds. Each entry says which. Worth a look if you are thinking about diversification within a thesis rather than concentration on one ticker.

There are three common ways to get DXC exposure. Buy shares (or fractional shares) directly at any major broker. Hold an ETF that includes it, which spreads the position across many companies. Or build it into a focused thematic portfolio, so DXC sits alongside other stocks that express the same thesis.

Walnut takes the portfolio route. Describe a thesis where DXC fits (for example “AI infrastructure” or “dividend-growth large-caps”) and the AI proposes 5 to 6 constituents with target weights. You review the plan and fund it through your own broker when you're ready.

New to this? Start with how to invest in stocks, see how to analyze a stock with AI, or compare the best AI stock analyzers.

DXC is a cash-rich, low-multiple IT services business whose investment case rests almost entirely on whether its AI-led repositioning can stop a multi-year revenue slide.

Whether DXC is worth buying today depends more on your time horizon and what you already hold than on any single call. We walk through valuation, what would have to go right, and the risks in is DXC a buy or a sell?, and where the stock could go from here in the DXC stock forecast.

For income investors, whether DXC pays a dividend and how the payout looks is covered in does DXC pay a dividend? And to weigh DXC against a peer, read the full side-by-side comparisons: DXC vs ACN and DXC vs IBM.